← Evidence map

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Hiroki Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29543226